Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 23% ± 1% | |
astrocyte | 3 studies | 23% ± 4% | |
glutamatergic neuron | 3 studies | 26% ± 3% |
Insufficient scRNA-seq data for expression of AADAT at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1226.05 | 245 / 245 | 100% | 32.65 | 502 / 502 |
thymus | 100% | 585.04 | 653 / 653 | 89% | 7.48 | 536 / 605 |
brain | 88% | 630.98 | 2333 / 2642 | 100% | 17.00 | 702 / 705 |
bladder | 100% | 745.86 | 21 / 21 | 87% | 10.47 | 437 / 504 |
intestine | 98% | 541.18 | 950 / 966 | 83% | 8.28 | 437 / 527 |
esophagus | 97% | 433.31 | 1405 / 1445 | 77% | 7.35 | 140 / 183 |
pancreas | 99% | 371.06 | 326 / 328 | 74% | 4.51 | 132 / 178 |
kidney | 100% | 384.29 | 89 / 89 | 72% | 4.20 | 647 / 901 |
lung | 98% | 441.29 | 569 / 578 | 72% | 6.02 | 829 / 1155 |
stomach | 97% | 347.95 | 348 / 359 | 70% | 6.40 | 201 / 286 |
uterus | 100% | 1146.45 | 170 / 170 | 64% | 7.25 | 296 / 459 |
liver | 100% | 1436.08 | 225 / 226 | 62% | 6.21 | 253 / 406 |
ovary | 100% | 437.13 | 180 / 180 | 58% | 4.22 | 248 / 430 |
adrenal gland | 87% | 180.52 | 224 / 258 | 70% | 9.08 | 161 / 230 |
breast | 99% | 340.96 | 456 / 459 | 51% | 5.11 | 571 / 1118 |
skin | 78% | 318.64 | 1410 / 1809 | 69% | 6.69 | 324 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.58 | 1 / 1 |
blood vessel | 100% | 648.55 | 1332 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 343.93 | 1195 / 1204 | 0% | 0 | 0 / 0 |
spleen | 86% | 176.20 | 208 / 241 | 0% | 0 | 0 / 0 |
heart | 83% | 174.86 | 715 / 861 | 0% | 0 | 0 / 0 |
muscle | 69% | 125.66 | 555 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 47% | 3.01 | 21 / 45 |
eye | 0% | 0 | 0 / 0 | 29% | 1.54 | 23 / 80 |
peripheral blood | 1% | 1.70 | 7 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006536 | Biological process | glutamate metabolic process |
GO_0033512 | Biological process | L-lysine catabolic process to acetyl-CoA via saccharopine |
GO_0006103 | Biological process | 2-oxoglutarate metabolic process |
GO_0070189 | Biological process | kynurenine metabolic process |
GO_0097052 | Biological process | L-kynurenine metabolic process |
GO_1901605 | Biological process | alpha-amino acid metabolic process |
GO_0009058 | Biological process | biosynthetic process |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0016212 | Molecular function | kynurenine-oxoglutarate transaminase activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0047958 | Molecular function | glycine:2-oxoglutarate aminotransferase activity |
GO_0047536 | Molecular function | 2-aminoadipate transaminase activity |
GO_0050094 | Molecular function | methionine-glyoxylate transaminase activity |
GO_0047315 | Molecular function | kynurenine-glyoxylate transaminase activity |
GO_0030170 | Molecular function | pyridoxal phosphate binding |
Gene name | AADAT |
Protein name | Aminoadipate aminotransferase, isoform CRA_b (cDNA, FLJ95590, Homo sapiens L-kynurenine/alpha-aminoadipate aminotransferase (KATII), mRNA) Aminoadipate aminotransferase Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial (KAT/AadAT) (2-aminoadipate aminotransferase) (2-aminoadipate transaminase) (EC 2.6.1.39) (Alpha-aminoadipate aminotransferase) (AadAT) (Glycine transaminase AADAT) (EC 2.6.1.4) (Kynurenine aminotransferase II) (Kynurenine--glyoxylate transaminase AADAT) (EC 2.6.1.63) (Kynurenine--oxoglutarate aminotransferase II) (Kynurenine--oxoglutarate transaminase 2) (EC 2.6.1.7) (Kynurenine--oxoglutarate transaminase II) (Methionine--glyoxylate transaminase AADAT) (EC 2.6.1.73) |
Synonyms | KYAT2 hCG_17308 KAT2 |
Description | FUNCTION: Transaminase with broad substrate specificity. Has transaminase activity towards aminoadipate, kynurenine, methionine and glutamate. Shows activity also towards tryptophan, aspartate and hydroxykynurenine. Accepts a variety of oxo-acids as amino-group acceptors, with a preference for 2-oxoglutarate, 2-oxocaproic acid, phenylpyruvate and alpha-oxo-gamma-methiol butyric acid. Can also use glyoxylate as amino-group acceptor (in vitro). . |
Accessions | ENST00000502392.1 D6RC56 Q4W5N8 ENST00000353187.6 [Q8N5Z0-1] ENST00000510340.5 ENST00000507375.5 ENST00000515480.5 [Q8N5Z0-1] D6REB9 Q8N5Z0 ENST00000337664.9 [Q8N5Z0-1] D6RFY7 ENST00000509167.5 [Q8N5Z0-2] |